BUPRENORPHINE AND METHADONE TREATMENT OF OPIATE DEPENDENCE DURING PREGNANCY: COMPARISON OF FETAL GROWTH AND NEONATAL OUTCOMES IN TWO CONSECUTIVE CASE SERIES
Saved in:
KAKKO, J., ET AL., BUPRENORPHINE AND METHADONE TREATMENT OF OPIATE DEPENDENCE DURING PREGNANCY: COMPARISON OF FETAL GROWTH AND NEONATAL OUTCOMES IN TWO CONSECUTIVE CASE SERIES. DRUG AND ALCOHOL DEPENDENCE, Vol. 96, no. 1-2 (2008), p. 69-78.
Ref.
153539
Location:
SIIS R.854 Archivo
Palabras clave:
Buprenorfina, Datos epidemiológicos, Drogodependencias, Embarazo, Feto, Heroína, Metadona, Mujer, Programas de mantenimiento, Recién nacido, Síndrome de abstinencia, Tratamiento
Buprenorfina, Datos epidemiológicos, Drogodependencias, Embarazo, Feto, Heroína, Metadona, Mujer, Programas de mantenimiento, Recién nacido, Síndrome de abstinencia, Tratamiento
Similar Items: BUPRENORPHINE AND METHADONE TREATMENT OF OPIATE DEPENDENCE DURING PREGNANCY: COMPARISON OF FETAL GROWTH AND NEONATAL OUTCOMES IN TWO CONSECUTIVE CASE SERIES
- USE OF BUPRENORPHINE IN PREGNANCY: PATIENT MANAGEMENT AND EFFECTS ON THE NEONATE
- CORRELATION BETWEEN FETAL ACTIVITY AND THE NEONATAL BEHAVIORAL ASSESSMENT SCALE
- CHALAMYDIA, GROUP B STREPTOCOCCUS AND HERPES IN PREGNANCY
- NEONATAL OUTCOME FOLLOWING BUPRENORPHINE MAINTENANCE DURING CONCEPTION AND THROUGHOUT PREGNANCY
- PREGNANCY OUTCOME AT 24-31 WEEKS' GESTATION: NEONATAL SURVIVORS
- FETAL GROWTH RESTRICTION AND SUBSEQUENT PREGNANCY RISKS